Liangjun Zhu

726 citations
25 papers · 477 indexed · h-index 10
Topics
Colorectal Cancer Treatments and Studies (13 papers)Genetic factors in colorectal cancer (7 papers)Lung Cancer Treatments and Mutations (6 papers)
Partner nations
ChinaUnited StatesEgypt

In The Last Decade

Liangjun Zhu

22 papers receiving 473 citations

Peers

Liangjun Zhu
Comparison fields: 5 of 53
  • Cancer Research 261
  • Oncology 229
  • Molecular Biology 191
  • Pulmonary and Respiratory Medicine 149
  • Pathology and Forensic Medicine 88
Replace Emne Ali Abdallah with:
Emne Ali Abdallah Brazil
Soo Hee Kim South Korea
Ming Yao China
Clarence Eng United States
M. Morell Spain
Ming Ouyang China
Ruofan Huang China
Shotaro Iwakiri Japan
Mark S. Rubin United States
Shruti Sharma United States
Liangjun Zhu relative to Emne Ali Abdallah Brazil Emne Ali Abdallah's profile →
Citations per field
00.5×1.7×
Emne Ali Abdallah · 1×
Citations per year

Countries citing papers authored by Liangjun Zhu

Since Specialization
Citations

This map shows the geographic impact of Liangjun Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangjun Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangjun Zhu more than expected).

Fields of papers citing papers by Liangjun Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangjun Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangjun Zhu. The network helps show where Liangjun Zhu may publish in the future.

Co-authorship network of co-authors of Liangjun Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Liangjun Zhu. A scholar is included among the top collaborators of Liangjun Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangjun Zhu. Liangjun Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 6
4 0
5 1
6 1
7 3
8 9
9 92
10 8
11 3
12 1
13 11
14 7
15 144
16 30
17 9
18 86
19 9
20 12

About Liangjun Zhu

Liangjun Zhu is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 25 papers that have together received 477 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (7 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (261 citations), Oncology (229 citations) and Pathology and Forensic Medicine (88 citations). Liangjun Zhu has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Zhenxin Wang, Zhili Chang, Xue Wu, Dandan Yin, Wei De, Yang Shao, Wei Li, Erbao Zhang, Liang Han and Xiaoling Tong. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026